Emergent BioSolutions (EBS) Other Operating Expenses (2013 - 2025)

Emergent BioSolutions' Other Operating Expenses history runs 10 years deep, the most recent figure standing at -$12.2 million for Q1 2025.

• In Q1 2025, Other Operating Expenses changed N/A year-over-year to -$12.2 million; the TTM figure through Dec 2025 stood at -$12.2 million (down 150.21% YoY), while the FY2025 annual figure was -$12.2 million, down 150.21% from the prior year.
• Other Operating Expenses was -$12.2 million for Q1 2025 at Emergent BioSolutions, down from $64.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $305.2 million in Q4 2021 to a low of -$40.0 million in Q2 2024.
• Historically, Other Operating Expenses has averaged $120.0 million across 5 years, with a median of $114.2 million in 2021.
• Biggest YoY gain for Other Operating Expenses was 9285.71% in 2024; the steepest drop was 153.4% in 2024.
• A 5-year view of Other Operating Expenses shows it stood at $305.2 million in 2021, then plunged by 44.33% to $169.9 million in 2022, then tumbled by 100.41% to -$700000.0 in 2023, then surged by 9285.71% to $64.3 million in 2024, then plunged by 118.97% to -$12.2 million in 2025.
• The last three Other Operating Expenses figures came in at -$12.2 million (Q1 2025), $64.3 million (Q3 2024), and -$40.0 million (Q2 2024), per Business Quant data.